A cluster RCT and process evaluation of an implementation optimisation intervention to promote parental engagement enrolment and attendance in a childhood obesity prevention programme: results of the Optimising Family Engagement in HENRY (OFTEN) trial.

Attendance Community Engagement Enrolment Obesity Parent

Journal

Trials
ISSN: 1745-6215
Titre abrégé: Trials
Pays: England
ID NLM: 101263253

Informations de publication

Date de publication:
05 Nov 2021
Historique:
received: 23 01 2021
accepted: 25 10 2021
entrez: 6 11 2021
pubmed: 7 11 2021
medline: 10 11 2021
Statut: epublish

Résumé

Poor and variable implementation of childhood obesity prevention programmes reduces their population impact and sustainability. We drew upon ethnographic work to develop a multi-level, theory-based implementation optimisation intervention. This intervention aimed to promote parental enrolment and attendance at HENRY (Health Exercise Nutrition for the Really Young), a UK community obesity prevention programme, by changing behaviours of children's centre and local authority stakeholders. We evaluated the effectiveness of the implementation optimisation intervention on HENRY programme enrolment and attendance over a 12-month implementation period in a cluster randomised controlled trial. We randomised 20 local government authorities (with 126 children's centres) to HENRY plus the implementation optimisation intervention or to HENRY alone. Primary outcomes were (1) the proportion of centres enrolling at least eight parents per programme and (2) the proportion of centres with a minimum of 75% of parents attending at least five of eight sessions per programme. Trial analyses adjusted for stratification factors (pre-randomisation implementation of HENRY, local authority size, deprivation) and allowed for cluster design. A parallel mixed-methods process evaluation used qualitative interviews and routine monitoring to explain trial results. Neither primary outcome differed significantly between groups; 17.8% of intervention centres and 18.0% of control centres achieved the parent enrolment target (adjusted difference - 1.2%; 95% CI - 19.5%, 17.1%); 17.1% of intervention centres and 13.9% of control centres achieved the attendance target (adjusted difference 1.2%; 95% CI - 15.7%, 18.1%). Unexpectedly, the trial coincided with substantial national service restructuring, including centre closures and reduced funds. Some commissioning and management teams stopped or reduced delivery of both HENRY and the implementation optimisation intervention due to competing demands. Thus, at follow-up, HENRY programmes were delivered to approximately half the number of parents compared to baseline (n = 433 vs. 881). During a period in which services were reduced by external policies, this first definitive trial found no evidence of effectiveness for an implementation optimisation intervention promoting parent enrolment to and attendance at an obesity prevention programme. ClinicalTrials.gov NCT02675699 . Registered on 4 February 2016.

Sections du résumé

BACKGROUND BACKGROUND
Poor and variable implementation of childhood obesity prevention programmes reduces their population impact and sustainability. We drew upon ethnographic work to develop a multi-level, theory-based implementation optimisation intervention. This intervention aimed to promote parental enrolment and attendance at HENRY (Health Exercise Nutrition for the Really Young), a UK community obesity prevention programme, by changing behaviours of children's centre and local authority stakeholders.
METHODS METHODS
We evaluated the effectiveness of the implementation optimisation intervention on HENRY programme enrolment and attendance over a 12-month implementation period in a cluster randomised controlled trial. We randomised 20 local government authorities (with 126 children's centres) to HENRY plus the implementation optimisation intervention or to HENRY alone. Primary outcomes were (1) the proportion of centres enrolling at least eight parents per programme and (2) the proportion of centres with a minimum of 75% of parents attending at least five of eight sessions per programme. Trial analyses adjusted for stratification factors (pre-randomisation implementation of HENRY, local authority size, deprivation) and allowed for cluster design. A parallel mixed-methods process evaluation used qualitative interviews and routine monitoring to explain trial results.
RESULTS RESULTS
Neither primary outcome differed significantly between groups; 17.8% of intervention centres and 18.0% of control centres achieved the parent enrolment target (adjusted difference - 1.2%; 95% CI - 19.5%, 17.1%); 17.1% of intervention centres and 13.9% of control centres achieved the attendance target (adjusted difference 1.2%; 95% CI - 15.7%, 18.1%). Unexpectedly, the trial coincided with substantial national service restructuring, including centre closures and reduced funds. Some commissioning and management teams stopped or reduced delivery of both HENRY and the implementation optimisation intervention due to competing demands. Thus, at follow-up, HENRY programmes were delivered to approximately half the number of parents compared to baseline (n = 433 vs. 881).
CONCLUSIONS CONCLUSIONS
During a period in which services were reduced by external policies, this first definitive trial found no evidence of effectiveness for an implementation optimisation intervention promoting parent enrolment to and attendance at an obesity prevention programme.
TRIAL REGISTRATION BACKGROUND
ClinicalTrials.gov NCT02675699 . Registered on 4 February 2016.

Identifiants

pubmed: 34740373
doi: 10.1186/s13063-021-05757-w
pii: 10.1186/s13063-021-05757-w
pmc: PMC8569980
doi:

Banques de données

ClinicalTrials.gov
['NCT02675699']

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

773

Subventions

Organisme : Research Trainees Coordinating Centre
ID : CDF-2014-07-052

Informations de copyright

© 2021. The Author(s).

Références

Clin Child Fam Psychol Rev. 2018 Sep;21(3):415-432
pubmed: 29611061
Pharmacoeconomics. 2019 Feb;37(2):201-226
pubmed: 30392040
BMC Public Health. 2020 Oct 12;20(1):1535
pubmed: 33046078
J Prim Prev. 2011 Dec;32(5-6):283-98
pubmed: 22134677
Cochrane Database Syst Rev. 2003;(3):CD001872
pubmed: 12917914
Community Pract. 2013 Jul;86(7):23-7
pubmed: 23914474
J Clin Child Adolesc Psychol. 2015;44(1):58-67
pubmed: 23688140
Matern Child Nutr. 2016 Jan;12(1):24-38
pubmed: 25894857
J Child Psychol Psychiatry. 2006 Jan;47(1):99-111
pubmed: 16405646
Cochrane Database Syst Rev. 2005 Jul 20;(3):CD001871
pubmed: 16034868
PLoS One. 2017 Mar 24;12(3):e0172584
pubmed: 28339460
BMC Med Res Methodol. 2008 Oct 09;8:65
pubmed: 18844993
Obesity (Silver Spring). 2007 Sep;15(9):2163-70
pubmed: 17890483
Health Technol Assess. 2011 Jan;15(2):1-182
pubmed: 21247515
J Child Adolesc Ment Health. 2009 Jun;21(1):29-38
pubmed: 25859638
J Nutr Educ Behav. 2007 May-Jun;39(3):142-9
pubmed: 17493564
Clin Child Fam Psychol Rev. 2014 Mar;17(1):85-96
pubmed: 23949334
Trials. 2017 Jan 24;18(1):40
pubmed: 28115006
Pilot Feasibility Stud. 2018 Jun 21;4:118
pubmed: 29977593
Eval Program Plann. 2013 Jun;38:19-27
pubmed: 23266400
BMJ. 2015 Mar 19;350:h1258
pubmed: 25791983
Health Educ Behav. 2014 Apr;41(2):127-37
pubmed: 23640123
BMJ. 2014 Mar 07;348:g1687
pubmed: 24609605
Pilot Feasibility Stud. 2021 Feb 26;7(1):59
pubmed: 33632330
Implement Sci. 2009 Aug 07;4:50
pubmed: 19664226
BMC Public Health. 2014 Dec 10;14:1256
pubmed: 25492496
J Clin Child Adolesc Psychol. 2010;39(3):302-13
pubmed: 20419572
J Dev Behav Pediatr. 2010 Nov-Dec;31(9):705-12
pubmed: 21057255
J Hum Nutr Diet. 2012 Oct;25(5):460-8
pubmed: 22489933
Ann Intern Med. 2011 Oct 4;155(7):434-47
pubmed: 21969342
Prev Sci. 2021 Apr;22(3):345-356
pubmed: 33523389
J Child Fam Stud. 2020 Jul;29(7):1957-1969
pubmed: 34334998
BMJ. 2004 Jun 26;328(7455):1561-3
pubmed: 15217878
Am J Prev Med. 2016 Jun;50(6):761-779
pubmed: 26916261
Pediatr Obes. 2014 Oct;9(5):339-50
pubmed: 23818487
Lancet. 2017 Feb 25;389(10071):823-833
pubmed: 28129989
Prev Chronic Dis. 2017 Jan 12;14:E03
pubmed: 28084989
Public Health. 2016 Jul;136:101-8
pubmed: 27184820
J Clin Child Adolesc Psychol. 2021 May-Jun;50(3):385-399
pubmed: 31910050
J Consult Clin Psychol. 2016 Dec;84(12):1094-1107
pubmed: 27599226
BMC Public Health. 2019 Aug 8;19(1):1074
pubmed: 31395041
Implement Sci. 2013 Feb 01;8:15
pubmed: 23375082
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2011 Mar;54(3):259-64
pubmed: 21347757
Child Care Health Dev. 2010 Nov;36(6):850-7
pubmed: 20637028
Child Care Health Dev. 2014 Nov;40(6):797-805
pubmed: 24134800
Clin Child Fam Psychol Rev. 2020 Jun;23(2):176-204
pubmed: 31820298
Clin Child Fam Psychol Rev. 2008 Dec;11(4):218-36
pubmed: 18836832

Auteurs

Maria Bryant (M)

Department of Health Sciences and the Hull York Medical School, University of York, YO105DD, York, UK. maria.bryant@york.ac.uk.
Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, LS2 9JT, UK. maria.bryant@york.ac.uk.

Wendy Burton (W)

Department of Health Sciences and the Hull York Medical School, University of York, YO105DD, York, UK.
Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, LS2 9JT, UK.

Michelle Collinson (M)

Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, LS2 9JT, UK.

Amanda Farrin (A)

Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, LS2 9JT, UK.

Jane Nixon (J)

Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, LS2 9JT, UK.

June Stevens (J)

Departments of Nutrition and Epidemiology, Gillings School of Public Health, University of North Carolina, Chapel Hill, NC, 27599, USA.

Kim Roberts (K)

HENRY Head Office, 8 Elm Place, Old Witney Road, Eynsham, OX29 4BD, UK.

Robbie Foy (R)

Academic Unit of Primary Care, Institute of Health Sciences, University of Leeds, Leeds, LS2 9JT, UK.

Harry Rutter (H)

London School of Hygiene and Tropical Medicine, 15-17 Tavistock Place, London, WC1H 9SH, UK.

Bethan Copsey (B)

Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, LS2 9JT, UK.

Suzanne Hartley (S)

Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, LS2 9JT, UK.

Sandy Tubeuf (S)

Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds, Leeds, LS2 9JT, UK.
IRSS-IRES, Université catholique de Louvain, B-1348, Louvain, La-Neuve, Belgium.

Julia Brown (J)

Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, LS2 9JT, UK.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH